针对阿尔茨海默病的多功能纳米载体:与障碍物做朋友
Mohammad Azam Ansari1, Takshashila Tripathi2, Baskar Venkidasamy3
1Department of Epidemic Disease Research, Institute for Research & Medical Consultations, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, 31441, Dammam, Saudi Arabia.
Molecular neurobiology
|November 15, 2023
概括
纳米医学提供了一种有前途的方法来对抗神经退行性疾病,利用纳米粒子 (NP) 通过血脑屏障提供向药物. 进一步的研究对于将这些纳米药物创新转化为阿尔茨海默病等疾病的有效临床治疗是必不可少的.
科学领域:
- 纳米医学是一种纳米医学.
- 神经科学是一个神经科学.
- 药物运输 药物运输 药物运输
背景情况:
- 神经退行性疾病 (NDD) 是一个日益严重的全球健康问题,其特点是神经元逐渐丧失.
- 目前用于阿尔茨海默病,帕金森病和亨廷顿病等NDD的治疗方法的有效性有限.
- 纳米粒子 (NP) 提出了一种新的策略,用于提高NDD管理的药物输送.
研究的目的:
- 审查纳米医学在治疗神经退行性疾病方面的潜力.
- 讨论针对NDDs的各种基于纳米粒子的药物递送系统.
- 要突出针对阿尔茨海默病治疗而研究的特定纳米配方.
主要方法:
- 关于纳米粒子在神经退行性疾病研究中的应用现有文献的综述.
- 不同类型的纳米粒子和纳米载体系统的分类.
- 对纳米配方的分析研究了阿尔茨海默病治疗潜力.
主要成果:
- 纳米药物可以有效地穿越血脑屏障,提供一种不那么侵入性的治疗选择.
- 包括聚合物,磁性和无机在内的各种NP类型显示出改善药物输送的前景.
- 对于阿尔茨海默氏症的治疗,正在探索特定的纳米配方,如N-丁烯酸和基于金属的NP.
结论:
- 纳米医学具有显著的潜力,可以彻底改变神经退行性疾病的治疗.
- 进一步的临床研究至关重要,以验证基于NP的疗法的疗效和安全性.
- 纳米粒子药物递送系统为管理衰弱的NDD提供了一个有希望的途径.
相关概念视频
01:22Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
01:26Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
130
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
130